When Apple introduced its fourth-gen smartwatch last year, the most striking feature it showcased was the ability to take electrocardiograms. The watch, since then, has proved to be a successful health companion and even managed to save lives by alerting users about their irregular heart activities.
Until now, though, the Apple Watch Series 4’s EKG tool had a limited reach courtesy of the $400 price tag and iOS exclusivity. Withings hopes to change that with its new Move ECG hybrid watch which can measure your heart’s rhythm patterns for a sum of just $129.95.
The new Withings Move ECG comes with an EKG and houses three electrodes for evaluating patterns, two of which are on the back of the watch and the third is embedded in the front bezel. To generate an electrocardiogram, users are simply required to touch both sides of the bezel (while wearing it, of course) and the watch will produce the readings if everything goes right. All of this data is accumulated in the hybrid watch’s companion app, Health Mate.
While the EKG feature is under FDA review, it’s worth noting that the wearable maker doesn’t necessarily need that to sell the watch. It essentially acts as a badge of reassurance and you shouldn’t rely merely on the watch for your EKGs anyway.
In addition to that, the Move ECG is your run-in-the-mill Withings hybrid watch capable of tracking your activities, steps, all while offering a solid battery life of a year. It costs $129.95 but if you’re not interested in the EKG tool, there’s a lower-end variant as well which is priced at $69.95. The Move ECG and Move hybrid watches will be available sometime in Q2, pre-orders for which are open today on the company’s website.